These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 25492830

  • 1. Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension.
    Oxlund CS, Buhl KB, Jacobsen IA, Hansen MR, Gram J, Henriksen JE, Schousboe K, Tarnow L, Jensen BL.
    J Am Soc Hypertens; 2014 Dec; 8(12):872-81. PubMed ID: 25492830
    [Abstract] [Full Text] [Related]

  • 2. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro.
    Buhl KB, Oxlund CS, Friis UG, Svenningsen P, Bistrup C, Jacobsen IA, Jensen BL.
    J Hypertens; 2014 Aug; 32(8):1672-7; discussion 1677. PubMed ID: 24805959
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.
    Andersen H, Hansen MH, Buhl KB, Stæhr M, Friis UG, Enggaard C, Supramaniyam S, Lund IK, Svenningsen P, Hansen PBL, Jensen BL.
    J Am Heart Assoc; 2020 Dec; 9(23):e016387. PubMed ID: 33215566
    [Abstract] [Full Text] [Related]

  • 4. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M, Buhl KB, Andersen RF, Svenningsen P, Nielsen F, Hinrichs GR, Bistrup C, Jensen BL.
    Am J Physiol Renal Physiol; 2015 Aug 01; 309(3):F235-41. PubMed ID: 25972510
    [Abstract] [Full Text] [Related]

  • 5. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
    Andersen H, Hansen PB, Bistrup C, Nielsen F, Henriksen JE, Jensen BL.
    J Hypertens; 2016 Aug 01; 34(8):1621-9. PubMed ID: 27214087
    [Abstract] [Full Text] [Related]

  • 6. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.
    Oxlund CS, Henriksen JE, Tarnow L, Schousboe K, Gram J, Jacobsen IA.
    J Hypertens; 2013 Oct 01; 31(10):2094-102. PubMed ID: 24107738
    [Abstract] [Full Text] [Related]

  • 7. Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report.
    Hinrichs GR, Mortensen LA, Jensen BL, Bistrup C.
    Physiol Rep; 2018 Jun 01; 6(12):e13743. PubMed ID: 29939487
    [Abstract] [Full Text] [Related]

  • 8. Urinary plasmin activates collecting duct ENaC current in preeclampsia.
    Buhl KB, Friis UG, Svenningsen P, Gulaveerasingam A, Ovesen P, Frederiksen-Møller B, Jespersen B, Bistrup C, Jensen BL.
    Hypertension; 2012 Nov 01; 60(5):1346-51. PubMed ID: 22987920
    [Abstract] [Full Text] [Related]

  • 9. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B, Weidmann P, Wohler D, Le Bloch Y.
    Am J Hypertens; 1996 Dec 01; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [Abstract] [Full Text] [Related]

  • 10. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
    Hinrichs GR, Weyer K, Friis UG, Svenningsen P, Lund IK, Nielsen R, Mollet G, Antignac C, Bistrup C, Jensen BL, Birn H.
    Acta Physiol (Oxf); 2019 Dec 01; 227(4):e13362. PubMed ID: 31423748
    [Abstract] [Full Text] [Related]

  • 11. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.
    Andersen H, Friis UG, Hansen PB, Svenningsen P, Henriksen JE, Jensen BL.
    Nephrol Dial Transplant; 2015 May 01; 30(5):781-9. PubMed ID: 25609736
    [Abstract] [Full Text] [Related]

  • 12. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Jensen JM, Pedersen EB.
    Clin Exp Hypertens; 2013 May 01; 35(5):313-24. PubMed ID: 22966789
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of renal NaCl retention in proteinuric disease.
    Svenningsen P, Friis UG, Versland JB, Buhl KB, Møller Frederiksen B, Andersen H, Zachar RM, Bistrup C, Skøtt O, Jørgensen JS, Andersen RF, Jensen BL.
    Acta Physiol (Oxf); 2013 Mar 01; 207(3):536-45. PubMed ID: 23216619
    [Abstract] [Full Text] [Related]

  • 14. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
    Nielsen SE, Persson F, Frandsen E, Sugaya T, Hess G, Zdunek D, Shjoedt KJ, Parving HH, Rossing P.
    Diabet Med; 2012 Aug 01; 29(8):e184-90. PubMed ID: 22268920
    [Abstract] [Full Text] [Related]

  • 15. Albuminuria in kidney transplant recipients is associated with increased urinary serine proteases and activation of the epithelial sodium channel.
    Hinrichs GR, Michelsen JS, Zachar R, Friis UG, Svenningsen P, Birn H, Bistrup C, Jensen BL.
    Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F151-F160. PubMed ID: 29363322
    [Abstract] [Full Text] [Related]

  • 16. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L.
    Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):137-42. PubMed ID: 22329591
    [Abstract] [Full Text] [Related]

  • 17. Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
    Izzo JL, Hong M, Hussain T, Osmond PJ.
    J Clin Hypertens (Greenwich); 2019 Aug 01; 21(8):1183-1190. PubMed ID: 31347775
    [Abstract] [Full Text] [Related]

  • 18. Urine albumin is a superior predictor of preeclampsia compared to urine plasminogen in type I diabetes patients.
    Nielsen LH, Jensen BL, Fuglsang J, Andersen LLT, Jensen DM, Jørgensen JS, Kitlen G, Ovesen P.
    J Am Soc Hypertens; 2018 Feb 01; 12(2):97-107. PubMed ID: 29305116
    [Abstract] [Full Text] [Related]

  • 19. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
    Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B.
    Clin J Am Soc Nephrol; 2006 Sep 01; 1(5):940-51. PubMed ID: 17699311
    [Abstract] [Full Text] [Related]

  • 20. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
    Václavík J, Sedlák R, Plachy M, Navrátil K, Plásek J, Jarkovsky J, Václavík T, Husár R, Kociánová E, Táborsky M.
    Hypertension; 2011 Jun 01; 57(6):1069-75. PubMed ID: 21536989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.